Prostate Cancer
Roundtables
Advances in Castrate-Resistant Prostate Cancer
News from the FDA/CDC
FDA approves first agent for PSMA-PET imaging in prostate cancer
The diagnostic agent Gallium 68 PSMA-11 has been approved for institutional use only.
Conference Coverage
Cancer therapy affects sexual health in most patients
Conference Coverage
Better continence rate gives robotic prostatectomy the edge
A large trial confirms early continence is better with a robotic rather than classical laparoscopic approach.
From the Journals
Genetic differences by ancestry shouldn’t impact efficacy of prostate cancer therapies
There were no significant differences in clinically actionable DNA repair genes, microsatellite instability-high status, or tumor mutation burden...
News from the FDA/CDC
FDA approves olaparib for certain metastatic prostate cancers
News from the FDA/CDC
First PARP inhibitor approved for metastatic prostate cancer
From the Journals
Combined biopsy method improves diagnostic accuracy in prostate cancer
Combining MRI-targeted and systematic biopsy resulted in 9.9% more prostate cancer diagnoses.